2018 Miami Breast Cancer Conference

Breast Cancer

How Will ctDNA Assays Aid in Managing Breast Cancer?

CIRCULATING TUMOR DNA (ctDNA) assays are now commercially available for use in lung cancer and melanoma, where they can identify the presence of specific mutations that drive treatment selection. In b...

Breast Cancer

Potent Anti-HER2 Agents on the Horizon

THANKS TO the efficacy of five approved anti-HER2 agents, patients with HER2-positive breast cancer have overall survival numbers that are as good as, or better than, their HER2-negative counterparts....

Advertisement

Advertisement



Advertisement